Clinical Utility and Outcome Prediction of Early ZnT8-IgG Testing and Titer in Type 1 Diabetes
INTRODUCTION: Type 1 diabetes autoantibodies are directed against multiple antigens including: glutamic acid decarboxylase, protein tyrosine phosphatase-like islet antigen 2 (IA2), insulin (IAA), and Zinc transporter 8 protein (ZnT8). The aim of our study was to determine if the presence or titer of...
Main Authors: | Amanda Dahl, Sarah Jenkins M., Siobhan J. Pittock, Siobhan T. Pittock |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayincilik
2023-03-01
|
Series: | JCRPE |
Subjects: | |
Online Access: | https://jcrpe.org/jvi.aspx?un=JCRPE-84856&volume=15&issue=1 |
Similar Items
-
Development of an immunoassay for the simultaneous detection of GADA and ZnT8A in autoimmune diabetes using a ZnT8/GAD65 chimeric molecule
by: Aldana Trabucchi, et al.
Published: (2023-08-01) -
Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus
by: Natalia I. Faccinetti, et al.
Published: (2017-11-01) -
Zinc transporter 8 (ZnT8) autoantibody prevalence in black South African participants with type 1 diabetes
by: Sureka Bhola, et al.
Published: (2021-07-01) -
ZnT8 autoantibody prevalence is low in youth with type 2 diabetes and associated with higher insulin sensitivity, lower insulin secretion, and lower disposition index
by: Janine Higgins, et al.
Published: (2022-09-01) -
The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
by: Navoda Atapattu, et al.
Published: (2023-02-01)